Chilly chain equipments (CCEs) at well being services (HFs) are an important a part of the immunization provide chain (ISC). The CCEs in authorities HFs of Delhi had been by no means assessed utilizing the World Well being Group-United Nations Kids’s Fund (WHO-UNICEF) Efficient Vaccine Administration (EVM) software besides that of state vaccine retailer throughout Nationwide EVM evaluation 2013.
The target of the examine was to evaluate the CCEs and their administration in authorities HFs utilizing the WHO-UNICEF EVM software in a district of Delhi. The evaluation was executed throughout December 2017-March 2018 in a single randomly chosen district of Delhi.
EIF3J Antibody |
45974-100ul |
SAB |
100ul |
EUR 302.4 |
EIF3J Antibody |
45974-50ul |
SAB |
50ul |
EUR 224.4 |
EIF3J Antibody |
47099-100ul |
SAB |
100ul |
EUR 302.4 |
EIF3J siRNA |
20-abx915181 |
Abbexa |
|
|
|
EIF3J siRNA |
20-abx915182 |
Abbexa |
|
|
|
EIF3J Antibody |
1-CSB-PA070117 |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000 |
EIF3J Antibody |
1-CSB-PA007539GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
EIF3J Antibody |
1-CSB-PA007539LA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
EIF3J Blocking Peptide |
20-abx061163 |
Abbexa |
|
|
|
EIF3J Rabbit pAb |
A8637-100ul |
Abclonal |
100 ul |
EUR 369.6 |
EIF3J Rabbit pAb |
A8637-200ul |
Abclonal |
200 ul |
EUR 550.8 |
EIF3J Rabbit pAb |
A8637-20ul |
Abclonal |
20 ul |
EUR 219.6 |
EIF3J Rabbit pAb |
A8637-50ul |
Abclonal |
50 ul |
EUR 267.6 |
EIF3J Conjugated Antibody |
C47099 |
SAB |
100ul |
EUR 476.4 |
EIF3J Conjugated Antibody |
C45974 |
SAB |
100ul |
EUR 476.4 |
EIF3J Blocking Peptide |
DF9509-BP |
Affbiotech |
1mg |
EUR 234 |
anti- EIF3J antibody |
FNab02711 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against EIF3J |
Anti-EIF3J antibody |
STJ113577 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: This gene encodes a core subunit of the eukaryotic initiation factor 3 complex, which participates in the initiation of translation by aiding in the recruitment of protein and mRNA components to the 40S ribosome. There are pseudogenes for this gene on chromosomes 1, 3, and 9. Alternative splicing results in multiple transcript variants encoding different isoforms. |
EIF3J protein (His tag) |
80R-2025 |
Fitzgerald |
50 ug |
EUR 508.8 |
Description: Recombinant human EIF3J protein (His tag) |
Human EIF3J shRNA Plasmid |
20-abx955704 |
Abbexa |
|
|
|
Phospho-EIF3J (Ser127) Antibody |
AF3761 |
Affbiotech |
100ul |
EUR 540 |
Rat EIF3J shRNA Plasmid |
20-abx991229 |
Abbexa |
|
|
|
EIF3J Antibody, HRP conjugated |
1-CSB-PA007539LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
EIF3J Antibody, FITC conjugated |
1-CSB-PA007539LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
EIF3J Antibody, Biotin conjugated |
1-CSB-PA007539LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF3J. Recognizes EIF3J from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
EIF3J Recombinant Protein (Rat) |
RP199367 |
ABM |
100 ug |
Ask for price |
EIF3J Recombinant Protein (Human) |
RP056415 |
ABM |
100 ug |
Ask for price |
EIF3J Recombinant Protein (Mouse) |
RP131294 |
ABM |
100 ug |
Ask for price |
Eif3j ORF Vector (Rat) (pORF) |
ORF066457 |
ABM |
1.0 ug DNA |
EUR 607.2 |
EIF3J ORF Vector (Human) (pORF) |
ORF018806 |
ABM |
1.0 ug DNA |
EUR 486 |
Eif3j ORF Vector (Mouse) (pORF) |
ORF043766 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Eif3j sgRNA CRISPR Lentivector set (Rat) |
K7490601 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
EIF3J sgRNA CRISPR Lentivector set (Human) |
K0668401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Eif3j sgRNA CRISPR Lentivector set (Mouse) |
K3550601 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Eif3j sgRNA CRISPR Lentivector (Rat) (Target 1) |
K7490602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3j sgRNA CRISPR Lentivector (Rat) (Target 2) |
K7490603 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3j sgRNA CRISPR Lentivector (Rat) (Target 3) |
K7490604 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF3J sgRNA CRISPR Lentivector (Human) (Target 1) |
K0668402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF3J sgRNA CRISPR Lentivector (Human) (Target 2) |
K0668403 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF3J sgRNA CRISPR Lentivector (Human) (Target 3) |
K0668404 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3j sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3550602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3j sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3550603 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif3j sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3550604 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF3J Protein Vector (Human) (pPB-C-His) |
PV075221 |
ABM |
500 ng |
EUR 662.4 |
EIF3J Protein Vector (Human) (pPB-N-His) |
PV075222 |
ABM |
500 ng |
EUR 662.4 |
EIF3J Protein Vector (Human) (pPM-C-HA) |
PV075223 |
ABM |
500 ng |
EUR 662.4 |
EIF3J Protein Vector (Human) (pPM-C-His) |
PV075224 |
ABM |
500 ng |
EUR 662.4 |
EIF3J Protein Vector (Mouse) (pPB-C-His) |
PV175062 |
ABM |
500 ng |
EUR 723.6 |
EIF3J Protein Vector (Mouse) (pPB-N-His) |
PV175063 |
ABM |
500 ng |
EUR 723.6 |
EIF3J Protein Vector (Mouse) (pPM-C-HA) |
PV175064 |
ABM |
500 ng |
EUR 723.6 |
EIF3J Protein Vector (Mouse) (pPM-C-His) |
PV175065 |
ABM |
500 ng |
EUR 723.6 |
EIF3J 3'UTR Luciferase Stable Cell Line |
TU006746 |
ABM |
1.0 ml |
EUR 1825.2 |
Eif3j 3'UTR GFP Stable Cell Line |
TU253889 |
ABM |
1.0 ml |
Ask for price |
Eif3j 3'UTR Luciferase Stable Cell Line |
TU105722 |
ABM |
1.0 ml |
Ask for price |
EIF3J 3'UTR GFP Stable Cell Line |
TU056746 |
ABM |
1.0 ml |
EUR 1825.2 |
Eif3j 3'UTR Luciferase Stable Cell Line |
TU203889 |
ABM |
1.0 ml |
Ask for price |
Eif3j 3'UTR GFP Stable Cell Line |
TU155722 |
ABM |
1.0 ml |
Ask for price |
EIF3J Protein Vector (Rat) (pPB-C-His) |
PV265826 |
ABM |
500 ng |
EUR 723.6 |
EIF3J Protein Vector (Rat) (pPB-N-His) |
PV265827 |
ABM |
500 ng |
EUR 723.6 |
EIF3J Protein Vector (Rat) (pPM-C-HA) |
PV265828 |
ABM |
500 ng |
EUR 723.6 |
EIF3J Protein Vector (Rat) (pPM-C-His) |
PV265829 |
ABM |
500 ng |
EUR 723.6 |
Recombinant Human EIF3J Protein, His, E.coli-10ug |
QP11768-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
Recombinant Human EIF3J Protein, His, E.coli-1mg |
QP11768-1mg |
EnQuireBio |
1mg |
EUR 6301.2 |
Recombinant Human EIF3J Protein, His, E.coli-2ug |
QP11768-2ug |
EnQuireBio |
2ug |
EUR 186 |
EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
LV679279 |
ABM |
1.0 ug DNA |
EUR 616.8 |
EIF3J Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
LV679283 |
ABM |
1.0 ug DNA |
EUR 616.8 |
EIF3J Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
LV679284 |
ABM |
1.0 ug DNA |
EUR 616.8 |
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
20-abx133581 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
20-abx123586 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
20-abx112377 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
20-abx315695 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
20-abx327824 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
abx232711-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody |
20-abx215117 |
Abbexa |
|
|
|
EIF3J Eukaryotic Translation Initiation Factor 3J Human Recombinant Protein |
PROTO75822 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: EIF3J Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 210 amino acids (70-258) and having a molecular mass of 24kDa (Molecular weight on SDS-PAGE will appear higher).;EIF3J is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody (HRP) |
20-abx315696 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody (FITC) |
20-abx315697 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) Antibody (Biotin) |
20-abx315698 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
K7490605 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K0668405 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3550605 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Human Eukaryotic Translation Initiation Factor 3 Subunit J (EIF3J) ELISA Kit |
abx387099-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
LV679280 |
ABM |
1.0 ug DNA |
EUR 616.8 |
EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
LV679281 |
ABM |
1.0 ug DNA |
EUR 686.4 |
EIF3J Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
LV679282 |
ABM |
1.0 ug DNA |
EUR 686.4 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
K7490606 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K7490607 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
K7490608 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K0668406 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K0668407 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF3J sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K0668408 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3550606 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3550607 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif3j sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3550608 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Pattern dimension and website choice had been executed utilizing the WHO EVM website choice software. A complete of 29 HFs had been assessed together with District Vaccine Retailer. Questions on CCEs in EVM software 1.0.9 had been used for knowledge assortment.Out of 56 electrical CCEs, 8.9% had been nonfunctional, 48.2% had been noncompliant with WHO requirements, 5.4% weren’t chlorofluorocarbon free, 4.7% didn’t have temperature monitoring system, and 18.8% didn’t have stabilizer.
Eighty-six % of passive containers had been compliant with the WHO requirements. The storage capability {of electrical} vaccine storage tools was inadequate in 3.4%, passive container capability in 65.5%, and ice packs preparation and storage capability in 24.1% of HFs. There was no deliberate preventive upkeep of CCEs and no commonplace working procedures for emergency occasion administration.
There was a scarcity of vaccine storage, ice packs preparation and storage, and passive container capability. Many CCEs utilized in ISC of assessed websites had been noncompliant to the WHO requirements. There was no PPM of CCEs and no pointers for emergency occasion administration.